bluebird bio, Inc. Interest Expense Nonoperating
bluebird bio, Inc. reported Interest Expense Nonoperating of $5.74 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2025-05-14
- bluebird bio, Inc. interest expense nonoperating for the quarter ending 2025-03-31 was $5.74M, a 18.27% increase year-over-year.
- bluebird bio, Inc. interest expense nonoperating for the quarter ending 2024-12-31 was $5.70M.
- bluebird bio, Inc. interest expense nonoperating for the quarter ending 2024-09-30 was $5.78M.
- bluebird bio, Inc. interest expense nonoperating for the quarter ending 2024-06-30 was $5.45M, a 45.41% increase year-over-year.
- bluebird bio, Inc. interest expense nonoperating for fiscal 2024 was $22.58M, a 38.07% increase from fiscal 2023.
- bluebird bio, Inc. interest expense nonoperating for fiscal 2023 was $16.35M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2025-03-31 | $5.74M 10-Q · filed 2025-05-14 | $11.45M derived: sum of 2 quarters · filed 2025-05-14 | $17.23M derived: sum of 3 quarters · filed 2025-05-14 | $22.68M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $11.48M derived: sum of 2 quarters · filed 2025-03-27 | $16.93M derived: sum of 3 quarters · filed 2025-03-27 | $22.58M 10-K · filed 2025-03-27 |
| 2024-09-30 | $5.78M 10-Q · filed 2024-11-14 | $11.23M derived: sum of 2 quarters · filed 2024-11-14 | $16.88M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $5.45M 10-Q · filed 2024-09-27 | $10.31M 10-Q · filed 2024-09-27 | ||
| 2024-03-31 | $4.86M 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $16.35M 10-K · filed 2025-03-27 | |||
| 2023-06-30 | $3.75M 10-Q · filed 2024-09-27 | $8.02M 10-Q · filed 2024-09-27 |